🟢 Cardio Diagnostics Holdings is trading 6.25% up in pre-market as broader risk appetite lifts U.S. equities

Cardio Diagnostics Holdings is trading 6.25% up at $2.04 as broader risk appetite lifted U.S. equities and related overnight trading.

• No new company-specific announcement was identified for September 22, 2026.
• September 18 shareholder approvals covered director elections and financing flexibility.
• Available reporting does not establish those approvals as the immediate catalyst; the move appears primarily aligned with wider market sentiment.